1.22
1.61%
-0.02
アフターアワーズ:
1.21
-0.01
-0.82%
Sellas Life Sciences Group Inc (SLS) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
0.079
|
- | - | - | - |
Cost Of Revenue |
-
|
- | - | - | - |
Operating Expenses
|
9.724
|
- | - | - | - |
Benefits Costs and Expenses |
9.645
|
- | - | - | - |
Costs And Expenses |
17.95%
9.645
|
8.177 | 9.361 | 9.05 | 11.28 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
17.95%
-9.645
|
-8.177 | -9.361 | -9.05 | -11.28 |
Net Interest Income/Expense |
92.68%
0.079
|
0.041 | 0.094 | 0.208 | 0.182 |
Nonoperating Income/Loss |
92.68%
0.079
|
0.041 | 0.094 | 0.21 | 0.184 |
Income/Loss From Continuing Operations Before Tax |
25.08%
-9.566
|
-7.648 | -9.361 | -9.05 | -11.28 |
Income/Loss From Continuing Operations After Tax |
17.58%
-9.566
|
-8.136 | -9.267 | -8.84 | -11.10 |
Net Income/Loss
|
17.58%
-9.566
|
-8.136 | -9.267 | -8.84 | -11.10 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
4,340%
44.81
|
1.0092 | 28.36 | 28.35 | 23.55 |
Diluted Average Shares |
4,340%
44.81
|
1.0092 | 28.36 | 28.35 | 23.55 |
Basic Earnings Per Share |
16.00%
-0.21
|
-0.25 | -0.33 | -0.31 | -0.47 |
Diluted Earnings Per Share |
16.00%
-0.21
|
-0.25 | -0.33 | -0.31 | -0.47 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):